Medline Inc. (MDLN) EV/EBIT Ratio: 19.75x
Is Medline Inc.’s EV/EBIT ratio high or low?
Medline Inc.'s EV/EBIT ratio of 19.75x is in line with its 1-year average of 21.22x, near the low end of its 1-year range (18.40x–24.46x).
As of Thursday, June 11, 2026. 6.91% below its 12-month average of 21.22x.
MDLN EV/EBIT Ratio Chart
MDLN Average EV/EBIT Ratio Chart
MDLN Current vs Average EV/EBIT Ratio Chart
MDLN EV/EBIT Ratio Metrics
EV/EBIT RATIO
19.75x
EV/EBIT RATIO AVG TTM
21.22x
EV/EBIT RATIO AVG 3Y
21.22x
EV/EBIT RATIO AVG 5Y
21.22x
EV/EBIT RATIO AVG 10Y
21.22x
EV/EBIT RATIO AVG 15Y
21.22x
EV/EBIT RATIO AVG 20Y
21.22x
CURRENT VS TTM AVG
-6.91%
CURRENT VS 3Y AVG
-6.91%
CURRENT VS 5Y AVG
-6.91%
CURRENT VS 10Y AVG
-6.91%
CURRENT VS 15Y AVG
-6.91%
CURRENT VS 20Y AVG
-6.91%
MDLN Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medline Inc. (MDLN) | $30.90B | 19.75x | 21.22x | 21.22x | 21.22x |
| IQVIA Holdings Inc. (IQV) | $30.08B | 13.37x | 20.38x | 24.02x | 30.00x |
| Centene Corporation (CNC) | $32.26B | N/A | 10.37x | 16.91x | 20.65x |
| Biogen Inc. (BIIB) | $28.94B | 20.85x | 13.29x | 14.80x | 15.73x |
| DexCom, Inc. (DXCM) | $28.92B | 28.80x | 38.63x | 65.25x | 101.86x |
| Zoetis Inc. (ZTS) | $34.27B | 11.71x | 17.86x | 24.01x | 27.37x |
| Veeva Systems Inc. (VEEV) | $26.31B | 26.56x | 45.54x | 60.66x | 66.33x |
| Agilent Technologies, Inc. (A) | $36.21B | 25.03x | 26.26x | 27.12x | 28.92x |
| Waters Corporation (WAT) | $23.21B | 54.26x | 27.55x | 26.51x | 26.24x |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 21.89x | 26.08x | 26.29x | 29.24x |
Medline Inc. EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medline Inc. EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for Medline Inc. (MDLN)?
- The EV/EBIT ratio for MDLN stock is 19.75x.
- Is Medline Inc.'s EV/EBIT ratio high or low?
- Medline Inc.'s EV/EBIT ratio of 19.75x is in line with its 1-year average of 21.22x, near the low end of its 1-year range (18.40x–24.46x).
- What is the TTM average EV/EBIT ratio for Medline Inc. (MDLN)?
- The TTM average EV/EBIT ratio for MDLN stock is 21.22x.
- What is the 3Y average EV/EBIT ratio for Medline Inc. (MDLN)?
- The 3Y average EV/EBIT ratio for MDLN stock is 21.22x.
- What is the 5Y average EV/EBIT ratio for Medline Inc. (MDLN)?
- The 5Y average EV/EBIT ratio for MDLN stock is 21.22x.
- What is the 10Y average EV/EBIT ratio for Medline Inc. (MDLN)?
- The 10Y average EV/EBIT ratio for MDLN stock is 21.22x.
- What is the 15Y average EV/EBIT ratio for Medline Inc. (MDLN)?
- The 15Y average EV/EBIT ratio for MDLN stock is 21.22x.
- What is the 20Y average EV/EBIT ratio for Medline Inc. (MDLN)?
- The 20Y average EV/EBIT ratio for MDLN stock is 21.22x.
Medline Inc. EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-10 | 19.75x |
| 2026-06-09 | 19.53x |
| 2026-06-08 | 18.64x |
| 2026-06-05 | 18.57x |
| 2026-06-04 | 18.91x |
| 2026-06-03 | 18.91x |
| 2026-06-02 | 18.40x |
| 2026-06-01 | 19.43x |
| 2026-05-29 | 19.76x |
| 2026-05-28 | 19.85x |
| 2026-05-27 | 19.47x |
| 2026-05-26 | 19.59x |
| 2026-05-22 | 19.94x |
| 2026-05-21 | 19.97x |
| 2026-05-20 | 19.63x |
| 2026-05-19 | 20.21x |
| 2026-05-18 | 19.54x |
| 2026-05-15 | 19.61x |
| 2026-05-14 | 20.70x |
| 2026-05-13 | 20.62x |
| 2026-05-12 | 20.56x |
| 2026-05-11 | 20.84x |
| 2026-05-08 | 20.95x |
| 2026-05-07 | 21.89x |
| 2026-05-06 | 21.95x |
| 2026-05-05 | 23.28x |
| 2026-05-04 | 22.83x |
| 2026-05-01 | 23.05x |
| 2026-04-30 | 22.94x |
| 2026-04-29 | 22.51x |
| 2026-04-28 | 22.85x |
| 2026-04-27 | 23.24x |
| 2026-04-24 | 23.06x |
| 2026-04-23 | 23.65x |
| 2026-04-22 | 24.02x |
| 2026-04-21 | 24.16x |
| 2026-04-20 | 24.46x |
| 2026-04-17 | 24.21x |
| 2026-04-16 | 23.93x |
| 2026-04-15 | 24.33x |
| 2026-04-14 | 24.23x |
| 2026-04-13 | 24.05x |
| 2026-04-10 | 23.39x |
| 2026-04-09 | 23.43x |
| 2026-04-08 | 22.89x |
| 2026-04-07 | 22.40x |
| 2026-04-06 | 22.70x |
| 2026-04-02 | 22.86x |
| 2026-04-01 | 22.75x |
| 2026-03-31 | 22.95x |
| 2026-03-30 | 22.19x |
| 2026-03-27 | 19.92x |
| 2026-03-26 | 20.23x |
| 2026-03-25 | 20.40x |
| 2026-03-24 | 20.17x |
| 2026-03-23 | 20.33x |
| 2026-03-20 | 20.42x |
| 2026-03-19 | 20.74x |
| 2026-03-18 | 20.25x |
| 2026-03-17 | 20.21x |
| 2026-03-16 | 20.06x |
| 2026-03-13 | 19.96x |
| 2026-03-12 | 19.82x |
| 2026-03-11 | 20.30x |
| 2026-03-10 | 20.48x |
| 2026-03-09 | 20.67x |
| 2026-03-06 | 20.83x |
| 2026-03-05 | 20.91x |
| 2026-03-04 | 20.48x |
| 2026-03-03 | 21.03x |
| 2026-03-02 | 21.56x |
| 2026-02-27 | 22.17x |
| 2026-02-26 | 22.68x |
| 2026-02-25 | 22.42x |
| 2026-02-24 | 23.08x |
| 2026-02-23 | 22.95x |
| 2026-02-20 | 23.01x |
| 2026-02-19 | 22.21x |
| 2026-02-18 | 22.25x |
| 2026-02-17 | 21.68x |
| 2026-02-13 | 21.09x |
| 2026-02-12 | 21.10x |
| 2026-02-11 | 21.27x |
| 2026-02-10 | 21.36x |
| 2026-02-09 | 22.12x |
| 2026-02-06 | 22.10x |
| 2026-02-05 | 21.69x |
| 2026-02-04 | 21.24x |
| 2026-02-03 | 21.15x |
| 2026-02-02 | 21.26x |
| 2026-01-30 | 20.96x |
| 2026-01-29 | 20.79x |
| 2026-01-28 | 21.00x |
| 2026-01-27 | 21.73x |
| 2026-01-26 | 21.20x |
| 2026-01-23 | 21.62x |
| 2026-01-22 | 21.61x |
| 2026-01-21 | 20.63x |
| 2026-01-20 | 20.94x |
| 2026-01-16 | 20.93x |
| 2026-01-15 | 20.42x |
| 2026-01-14 | 20.67x |
| 2026-01-13 | 20.47x |
| 2026-01-12 | 20.42x |
| 2026-01-09 | 19.61x |
| 2026-01-08 | 19.88x |
| 2026-01-07 | 19.58x |
| 2026-01-06 | 19.34x |
| 2026-01-05 | 19.06x |
| 2026-01-02 | 19.65x |
| 2025-12-31 | 20.16x |
| 2025-12-30 | 20.56x |
| 2025-12-29 | 20.59x |
| 2025-12-26 | 21.30x |
| 2025-12-24 | 21.35x |
| 2025-12-23 | 21.13x |
| 2025-12-22 | 20.65x |
| 2025-12-19 | 20.47x |
| 2025-12-18 | 19.76x |
| 2025-12-17 | 20.26x |
Related Metrics
About Medline Inc.
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions. The Medline Brand division focuses on the production and sourcing of its proprietary medical products, categorized into three key areas: Within Frontline Care, Medline provides a wide array of patient-facing medical and surgical items. This encompasses essentials like wound care treatments, examination gloves, skin and incontinence products, sanitation supplies, various textiles, hand sanitizers, durable medical equipment (DME), patient-specific plastic goods, and decolonization and infection control solutions. The Surgical Solutions category delivers comprehensive product lines for operating rooms and perioperative settings. Offerings range from surgical procedure trays, drapes, and gowns to personal protective equipment (PPE), sterile wraps, various surgical instruments, specialized surgeon's gloves, complete procedure kits, and orthopedic implants. Finally, Laboratory and Diagnostics supplies critical solutions for clinical testing and analysis. This includes point-of-care testing devices, analytical instruments, laboratory consumables, advanced diagnostic equipment, vital signs monitoring systems, and products for anatomic pathology and phlebotomy. The Supply Chain Solutions segment is responsible for sourcing and distributing a diverse portfolio of third-party products, including those from well-known national brands. Beyond distribution, this segment offers comprehensive logistics and supply chain optimization services to clients both domestically and internationally. These optimization services encompass strategic consulting, outsourced management of warehousing and technology, specialized "put-away-ready" packaging, third-party logistics (3PL), inventory rationalization strategies, and efficient route planning. Established in 1966, Medline Inc. maintains its headquarters in Northfield, Illinois.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- James Boyle